Alan Saul Selected Research

Alan Saul Research Topics

4	Ganglion Cysts (Ganglion) 01/2017 - 09/2011
2	Multiple Sclerosis 01/2020 - 12/2016
2	Inflammation (Inflammations) 01/2020 - 12/2016
2	Glaucoma 01/2019 - 11/2016
2	Hyperhomocysteinemia 01/2019 - 04/2015
2	Gliosis 01/2019 - 01/2017
2	Optic Nerve Diseases (Optic Neuropathy) 11/2016 - 09/2011
2	Retinopathy of Prematurity (Retrolental Fibroplasia) 11/2016 - 01/2011
2	Blindness (Hysterical Blindness) 11/2016 - 01/2016
2	Ischemia 11/2016 - 01/2011
2	Methylenetetrahydrofolate reductase deficiency 01/2016 - 04/2015
1	Obesity 01/2020
1	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020
1	Sickle Cell Anemia (Hemoglobin S Disease) 12/2016
1	Vision Disorders (Hemeralopia) 11/2016
1	Reperfusion Injury 11/2016
1	Diabetic Retinopathy (Retinopathy, Diabetic) 11/2016
1	Retinal Degeneration 01/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016
1	Retinal Diseases 01/2012

11	Retinaldehyde (Retinal)IBA 01/2020 - 01/2011
3	ArginaseIBA 01/2020 - 01/2011
1	InflammasomesIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 01/2020
1	citraconic acid (mesaconic acid)IBA 01/2020
1	LigandsIBA 01/2020
1	Pentazocine (Talwin)FDA LinkGeneric 01/2020
1	Neuroprotective AgentsIBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Excitatory Amino AcidsIBA 01/2019
1	HomocysteineIBA 01/2019
1	Peanut AgglutininIBA 01/2017
1	monomethyl fumarateIBA 12/2016
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2016
1	Molecular Chaperones (Chaperone, Molecular)IBA 01/2016
1	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 04/2015
1	CaspasesIBA 09/2011

1	Therapeutics 12/2016